| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |